Barrier Therapeutics Inc., of Princeton, N.J., appointed Al Altomari global head, business development and commercial operations...Chiron Corp., of Emeryville, Calif., said Andrew Heaton, its vice president and chief medical officer, Chiron blood testing division, was appointed to the federal advisory committee of blood safety and availability

Millennium Pharmaceuticals Inc., of Cambridge, Mass., named Kenneth Bate executive vice president, head of commercial operations and chief financial officer...Also, it appointed Marsha Fanucci vice president of finance and corporate strategy...Molecular Imaging Research Inc., of Ann Arbor, Mich., appointed Wilbur Leopold president and William Elliot vice president

Chiron Corp., of Emeryville, Calif., appointed Kenneth Bair senior vice president, head of biopharma research, Chiron BioPharmaceuticals, and Carl Pelzel senior vice president, biopharma commercial operations, Chiron BioPharmaceuticals...and Tom McCall as director, engineering and manufacturing technology

Exelixis Inc., of South San Francisco, appointed Steven James senior vice president, commercial operations...Indevus Pharmaceuticals Inc., of Lexington, Mass., elected Cheryl Morley and Stephen McCluski to its board...Nuvelo Inc., of Sunnyvale, Calif., appointed Jan Johansson chief medical officer and vice president, clinical affairs

and Joanne Harack vice president, human resources and corporate communications...Cephalon Inc., of West Chester, Pa., appointed Martin Reeves vice president, project management and Randy Bradway vice president, logistics, distribution and trade relations commercial operations

Acacia Research Corp., of Newport Beach, Calif., named Amit Kumar and Rigdon Currie to its board...Ambion Inc., of Austin, Texas, named Jeffrey Williams executive vice president and general manager of Ambion RNA Diagnostics...Synbiotics Corp., of San Diego, added Paul Hays as president and chief operating officer

Serologicals Corp., of Atlanta, added David Bellitt as vice president, global commercial operations...Also, Niclas Stiernholm, executive vice president and chief scientific officer, left the company, although he is now part of its scientific advisory board

Biogen Inc., of Cambridge, Mass., appointed Whaijen Soo senior vice president, medical research and Bob Hamm senior vice president of North American commercial operations...Hybridon Inc., of Cambridge, Mass., elected William Reardon and Georges Marcel to its board

AtheroGenics Inc., of Atlanta, elected David Bearman to its board and to serve on its audit committee...Ceregene Inc., of San Diego, appointed Raymond Bartus vice president of research and development...NuGen Technologies Inc., of San Carlos, Calif., appointed James Stanchfield vice president of commercial operations

ProdiGene Inc., of College Station, Texas, said its CEO and president, Anthony Laos, was appointed by President George W. Bush to serve as a member of the Board for International Food and Agriculture Development...It also promoted William Aliski to vice president, commercial operations

Prima Biomed Ltd., of Melbourne, Australia, appointed John Bates research and development manager...Sicor Inc., of Irvine, Calif., elected Sanford Miller and Michael Casey to its board...Vertex Pharmaceuticals Inc., of Cambridge, Mass., named Anthony Coles senior vice president, commercial operations-pharmaceutical products

AlleCure Corp., of Valencia, Calif., appointed Thomas Lobl vice president of research and development...CuraGen Corp., of New Haven, Conn., elected David Ebsworth and John Forsgren to its board...Munich Biotechnology AG, of Martinsried, Germany, appointed Michael Witzel, Eric Stoer and Torsten Goesch to its supervisory board

PPD Inc., of Wilmington, N.C., named Fred Davenport president and promoted Paul Covington to executive vice president of development...RxKinetix Inc., of Louisville, Colo., named John Carpenter, Mark Manning and Ted Randolph to its scientific advisory board...ViaCell Inc., of Boston, added Robert Silverman as senior vice president, commercial operations

Biogen Inc., of Cambridge, Mass., named Robert Hamm senior vice president-international, added Guy-Charles Fanneau dela Horie as vice president, strategic commercial operations-international and appointed Patrick Vink vice president, sales, responsible for international affiliates...CytoGenix Inc., of Houston, appointed Yin Chen vice president of research and development and added Charles Boyd and Nhan Nguyen to its board...Large Scale Biology Corp., of Vacaville, Calif., named John Fowler president

Orphan Medical Inc., of Minneapolis, added Pamela Stahl as vice president of commercial operations...Zyomyx Inc., of Hayward, Calif., appointed Nicholas Naclerio senior vice president and chief business officer

and promoted Sergio Garcia-Rodriguez to vice president, legal, general counsel and assistant secretary...Questcor Pharmaceuticals Inc., of Union City, Calif., appointed Timothy Morris vice president of finance/administration and chief financial officer and Kenneth Greathouse vice president, commercial operations

Biogen Inc., of Cambridge, Mass., appointed Hans-Peter Hasler executive vice president, commercial operations...Elitra Pharmaceuticals Inc., of San Diego, appointed Martin Rosenberg to its board and scientific advisory board and Philip Youngman vice president of discovery biology

ExonHit Therapeutics SA, of Paris, appointed Pierre Corvol and Dominique Stehelin to its scientific advisory board...He will continue to serve as controller and chief accounting officer...ICOS Corp., of Bothell, Wash., appointed Michael Stein vice president and chief financial officer

Guilford Pharmaceuticals Inc., of Baltimore, appointed David Wright executive vice president, commercial operations and Margaret Contessa vice president of human resources...and added Eliel Bayever, William Freimuth and Ann Wang to its clinical development group